Re-examination Study of EMEND (Aprepitant) (MK-0869-184)

Clinical trial NCT01074255 · COMPLETED

Trial details

NCT number: NCT01074255
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Chemotherapy-induced Nausea and Vomiting

Start date: 2007-04-01
Primary completion: 2011-10-01
Enrollment: 3546

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.